Global Alopecia Market- Market Overview:

The global alopecia market is expected to grow from USD 8.4 billion in 2022 to USD 15.8 billion by 2030, at a CAGR of 8.2% during the Projection period 2023-2030. The growth of this market is mainly driven owing to the increasing prevalence of hair loss among people from all age groups.

Spot baldness is another name for alopecia areata. It is a medical disorder in which all or partial body parts lose their hair. Frequently, it causes a few bald spots to appear on people's scalps. Typically, a spot is the size of a penny. In rare instances, the entire head or body's hair may fall out permanently. A breach in the immunological privilege of the hair follicles can cause alopecia areata, an autoimmune illness. A family history of the same illness is one risk factor for alopecia areata. The mechanism involves the body's inability to identify its own cells as a result of the hair follicle's loss. There is currently no known treatment for the condition, however various drugs are being explored for regrowth, such as cortisone injections, sunscreen to protect the affected area from the sun and cold, and glasses if eyelashes have been damaged or are absent. Another kind of androgenetic alopecia, known as male-pattern baldness in men, is widespread in both sexes. In this instance, hair loss is clearly specified. After some time, the 'M'-shaped hairline foam feature is frequently on the way to partial or total baldness. It is a different condition for girls than it is for guys. Women have thinning hair all over the head, which frequently progresses to total baldness. Men who have certain medical disorders, such as coronary heart disease, prostate enlargement, hypertension, and many others, are more likely to develop androgenetic alopecia.

Sample Request: - Global Alopecia Market

Market Dynamics:

Drivers:                          

• Increasing prevalence of hair loss

The market for alopecia areata is expected to rise as hair loss becomes more common. According to the American Academy of Dermatology Association (AAD), around 30 million women and 50 million men in the US were estimated to have alopecia in 2018. Around 60% of people experience hair thinning, with pattern hair loss being the most prevalent kind of hair loss in both men and women, according to the Journal of Clinical and Diagnostic Research (JCDR). Additionally, regardless of gender, 2% of the general population is susceptible to developing alopecia areata in their lifetime.

• Increasing investment for healthcare infrastructure

The increasing cost of healthcare contributes to the development of the market for alopecia areata and has a significant impact on its growth rate. An increase in the number of initiatives being carried out by groups like the American Hair Loss Association and the National Alopecia Areata Foundation to spread knowledge about hair regrowth and treatment options is what is causing a rise in healthcare spending.

Restraints:         

• High Cost of treatment

The high cost of the treatment will hinder the market's growth rate. The market for alopecia areata will be impacted by limited primary care services and a lack of healthcare infrastructure in emerging nations. Additionally, during the projected period, rigorous regulatory rules and a lack of public awareness would serve as restraints and further restrict the market's growth pace.

Opportunities:

• An increase in the number of R&D activity

The market is expanding as a result of increasing research and development activity. This will present advantageous opportunities for the market for alopecia areata to expand. Along with this, an increase in drug releases and approvals will speed up the market's expansion. Alopecia areata market growth will also benefit from increased investments in the development of cutting-edge technologies and an increase in the number of emerging markets during the Projection period.

Challenges:

• Lack of proper reimbursement policies

Reimbursement is still a significant issue in this market. The majority of treatment techniques for hair loss are not covered by insurance policies since they are seen as aesthetic procedures rather than medically necessary procedures. In general, out-of-pocket expenses for treating alopecia include copays for prescription medications, frequent doctor visits, and co-insurance for treatment methods. The market's expansion may also be hampered by the growing use of alternatives like traditional treatments like Ayurvedic, Chinese, and homemade pharmaceuticals.

Segmentation Analysis:

The global alopecia market has been segmented based on disease type, treatment, end-user, and region.

By Disease Type

The disease type segment includes alopecia areata, androgenetic alopecia, cicatricial, traction and others. The alopecia areata segment led the largest share of the alopecia market with a market share of around 29% in 2022. Researchers do not fully understand what causes the immune system to attack hair follicles in alopecia areata, but they believe genetic and environmental factors both play a part. Alopecia areata cannot be cured; however, it can be treated, and the hair can grow back. Alopecia is often treated with medications used to treat other medical conditions. In the projected period, the alopecia market is expected to grow significantly due to the discovery of innovative therapies and supportive measures during the approval process. As an example, Incyte Corporation and Eli Lilly and Company received the U.S. FDA's Breakthrough Therapy Designation in March 2020 for the treatment of AA. This designation will expedite the approval process.

By Treatment

The treatment segment includes devices and pharmaceuticals. The alopecia areata segment led the largest share of the alopecia market with a market share of around 59% in 2022. A high share of the market was controlled by the pharmaceutical industry, which generated the highest revenue share. This category is largely driven by the low cost of pharmaceutical items and the increased use of prescriptions and over-the-counter medications. Finasteride and minoxidil are the most commonly used medications for treating hair loss.

By End-Users

The end-users segment includes homecare, dermatology clinics, hospitals and others. The front/headlamps segment led the largest share of the alopecia market with a market share of around 32% in 2022. A significant portion of the market will be dominated by dermatology clinics during the Projection period, driven by newer technologies and appropriate medications. A new type of laser therapy which stimulates hair growth will increase treatment rates among patients with hair loss, boosts the growth of the market.

Global Alopecia Market- Sales Analysis.

The sale of alopecia expanded at a CAGR of 7.9% from 2016 to 2022.

Growing healthcare expenditures are another significant factor contributing to alopecia market growth, as they help to improve the infrastructure of the market. By conducting more activities to raise awareness about hair regrowth and treatment alternatives, organizations such as the National Alopecia Areata Foundation and the American Hair Loss Association are driving an increase in healthcare expenditures.

Continuous research and development by various major key players are creating more growth opportunities for the market growth. Rising awareness about such treatments among the patients are driving the market in various regions. Hair loss treatment rate is also expected to increase in the near future due to the prevalence of diseases related to hair loss, such as cancer, polycystic ovarian syndrome, and rheumatoid arthritis.

Thus, owing to the aforementioned factors, the global alopecia market is expected to grow at a CAGR of 8.2% during the Projection period from 2023 to 2030.

By Regional Analysis:

The regions analyzed for the alopecia market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. The North American region dominated the alopecia market and held a 37.5% share of the market revenue in 2022.

• The North American region witnessed a major shaThere was a strong dominance of North America and a significant amount of revenue generated, all contributing factors to its growth include a high prevalence of diseases, increased consumer awareness, proactive government action, technological advances, and improvements to the healthcare infrastructure, among others. Several important companies operate in this area, which is a major driver of its growth.In addition, laser-based treatments are becoming more common in the region, which is contributing a large share in the growth of the market.
• Asia Pacific is anticipated to experience significant growth during the predicted period. During the projected period, the Asia Pacific market is expected to grow at the fastest CAGR as consumer awareness, disposable income, and product penetration increase. Furthermore, improving the healthcare regulatory environment in emerging nations is expected to attract foreign investors and create new business opportunities for them.

Global Alopecia Market - Country Analysis:

• Germany

Germany's alopecia market size was valued at USD 0.67 billion in 2022 and is expected to reach USD 1.26 billion by 2030, at a CAGR of 8.3% from 2023 to 2030.

Market growth is largely attributed to the development of technology and awareness programs that are run by both governmental and commercial organizations. A significant part of the European Hair Research Society's mission is to promote knowledge about the best methods for treating and preventing hair loss.

• China

China’s alopecia market size was valued at USD 0.70 billion in 2022 and is expected to reach USD 1.34 billion by 2030, at a CAGR of 8.5% from 2023 to 2030.

Increasing demand for effective hair loss treatment pharmaceuticals, particularly oral treatments, is the primary driver of the Chinese alopecia market. Due to their ability to reduce the number of prescription dosages while increasing therapeutic efficacy, oral hair loss treatment medicines have become increasingly popular because they help to ensure patient safety.

• India

India's alopecia market size was valued at USD 0.52 billion in 2022 and is expected to reach USD 0.99 billion by 2030, at a CAGR of 8.4% from 2023 to 2030.

Due to increased emphasis on enhancing aesthetic appearance, patients' interest in novel and emerging treatment modalities for alopecia is being increased by growing popularity of cosmetic operations. As a result, the country's market revenue is expected to grow further.

Key Industry Players Analysis:  

To increase their market position in the global alopecia market business, top companies focus on tactics such as adopting new technology, mergers & acquisitions, product developments, collaborations, partnerships, joint ventures, etc.

• Merck & Co. Inc.
• Lupin
• Abbott
• Hoffman-La Roche Ltd.
• Sanofi
• Eli Lilly and Company
• AbbVie Inc.
• Cipla Inc.
• Mylan N.V.
• GlaxoSmithKline
• Bayer AG
• Allergan
• Johnson & Johnson Private Limited
• Teva Pharmaceutical Industries Ltd.

Latest Development:

• In August 2021, Reimbursement is still a significant issue in this market. The majority of treatment techniques for hair loss are not covered by insurance policies since they are seen as aesthetic procedures rather than medically necessary procedures. In general, out-of-pocket expenses for treating alopecia include copays for prescription medications, frequent doctor visits, and co-insurance for treatment methods. The market's expansion may also be hampered by the growing use of alternatives like traditional treatments like Ayurvedic, Chinese, and homemade pharmaceuticals.

Report Metrics

Report Attribute	Details
Study Period	2022-2030
Base year	2022
CAGR (%)	8.2%
Market Size	8.4 billion in 2022
Projection period	2023-2030
Projection unit	Value (USD)
Segments covered	By Disease Type, By Treatment, By End-User, and By Region.
Report Scope	Revenue Projection, competitive landscape, company ranking, growth factors, and trends
Companies covered	Merck & Co. Inc., Lupin, Abbott, F. Hoffman-La Roche Ltd., Sanofi, Eli Lilly and Company, AbbVie Inc., Cipla Inc., Mylan N.V., GlaxoSmithKline, Bayer AG, Allergan, Johnson & Johnson Private Limited, and Teva Pharmaceutical Industries Ltd.
By Disease Type	Alopecia Areata Androgenetic Alopecia Cicatricial Traction Others
By Treatment	Devices Pharmaceuticals
By End-User	Homecare Dermatology Clinics Hospitals Others
Regional scope	North America Europe Asia-Pacific South America Middle East and Africa

Scope of the Report

Global Alopecia Market by Disease Type:

• Alopecia Areata
• Androgenetic Alopecia
• Cicatricial
• Traction
• Others

Global Alopecia Market by Treatment:

• Devices
• Pharmaceuticals

Global Alopecia Market by End-Users:

• Homecare
• Dermatology Clinics
• Hospitals
• Others

Global Alopecia Market by Region:

• North America
  • USA
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
• Asia-Pacific
  • Japan
  • China
  • India
  • Korea
  • Southeast Asia
• South America
  • Brazil
  • Peru
• Middle East and Africa
  • UAE
  • South Africa
  • Saudi Arabia

Political Factors- Before deciding whether to expand, the alopecia market should extensively examine the appropriate taxation policies. Tax policy will benefit industries that are top priorities for the government more. Many governments in developing countries are actively attempting to reduce company taxes in order to attract foreign direct investment. The alopecia industry should consider these countries because their low tax rates will make it easier to turn a profit and invest in R&D, innovation, and new product development projects.

Economical Factors- Rising inflation diminishes the purchasing power of money and discourages people from spending on products and services, which may have a negative impact on the alopecia market's ability to increase revenue. Changes in exchange rates can have an impact on a company's profitability. The alopecia market should conduct this research in order to accurately estimate exchange rate variations and avoid unwanted trade and business performance repercussions. A high interest rate indicates that the alopecia market will have to make interest-only payments, raising the entire cost of the loans acquired.

Social Factor- Consumption trends and economic challenges are inextricably linked. When customers have more disposable income and are prepared to spend more on goods and services to better their lifestyles, the alopecia market benefits from exciting growth potential. This is because it is easier to introduce new products and services to these clients, and the prospects of revenue growth are also higher. In order to adjust its marketing mix strategies, the alopecia industry must closely evaluate the consumption/spending patterns and tastes of modern consumers, who are increasingly demanding. The alopecia market must also understand whether consumption is motivated by hedonic or utilitarian motives. The degree of ethnocentrism is an important consumer behaviour component that might affect the success of the alopecia market.

Technological Factors- The alopecia market should favour countries with sophisticated technological infrastructure since these countries make it easier for enterprises to pursue objectives such as cost reduction, innovation, and value creation. A well-developed technological infrastructure also indicates that it will be more difficult for the alopecia market to use technology to create a sustainable competitive advantage because it might be quickly replicated by competitors. By making the necessary technical expenditures, the alopecia market can improve customer experience, produce operational savings, and identify itself as an innovative firm.

Environmental Factors- The alopecia market should favour countries with sophisticated technological infrastructure since these countries make it easier for enterprises to pursue objectives such as cost reduction, innovation, and value creation. A well-developed technological infrastructure also indicates that it will be more difficult for the alopecia market to use technology to create a sustainable competitive advantage because it might be quickly replicated by competitors. By making the necessary technical expenditures, the alopecia market can improve customer experience, produce operational savings, and identify itself as an innovative firm.

Legal Factors- Employment law is a large area of laws that safeguard employees' rights, such as the right to a fair wage, equality, equity, inclusion, justice, and physical and mental safety. While some countries lack effective enforcement of employment laws, others impose hefty penalties for breaking any of the listed employee rights. When entering or operating in such countries, the alopecia market should ensure the safety of the working environment. Appropriate systems must be in place to prevent both direct and indirect discrimination. In the ever-increasing battle for talent, efficient compliance with employment standards can help the alopecia market improve its employer brand reputation, which is crucial for attracting and retaining top talent.

1. Introduction
   • 1. Objectives of the Study
   • 2. Market Definition
   • 3. Research Scope
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
   • 1. Porter’s Five Forces Analysis
   • 2. Value Chain Analysis
   • 3. Top Investment Pockets
     • 3.1. Market Attractiveness Analysis By Disease Type
     • 3.2. Market Attractiveness Analysis By Treatment
     • 3.3. Market Attractiveness Analysis By End-User
     • 3.4. Market Attractiveness Analysis By Region
   • 4. Industry Trends
5. Market Dynamics
   • 1. Market Evaluation
   • 2. Drivers
     • 2.1. Increasing prevalence of hair loss
   • 3. Restraints
     • 3.1. High Cost of treatment
   • 4. Opportunities
     • 4.1. An increase in the number of R&D activity  
   • 5. Challenges
     • 5.1. Lack of proper reimbursement policies

6. Global Alopecia Market Analysis and Projection, By Disease Type
   • 1. Segment Overview
   • 2. Alopecia Areata
   • 3. Androgenetic Alopecia
   • 4. Cicatricial
   • 5. Traction
   • 6. Others
7. Global Alopecia Market Analysis and Projection, By Treatment
   • 1. Segment Overview
   • 2. Devices
   • 3. Pharmaceuticals
8. Global Alopecia Market Analysis and Projection, By End-User
   • 1. Segment Overview
   • 2. Homecare
   • 3. Dermatology Clinics
   • 4. Hospitals
   • 5. Others
9. Global Alopecia Market Analysis and Projection, By Regional Analysis
   • 1. Segment Overview
   • 2. North America
     • 2.1. U.S.
     • 2.2. Canada
     • 2.3. Mexico
   • 3. Europe
     • 3.1. Germany
     • 3.2. France
     • 3.3. U.K.
     • 3.4. Italy
     • 3.5. Spain
   • 4. Asia-Pacific
     • 4.1. Japan
     • 4.2. China
     • 4.3. India
   • 5. South America
     • 5.1. Brazil
   • 6. Middle East and Africa
     • 6.1. UAE
     • 6.2. South Africa

10. Global Alopecia Market-Competitive Landscape
    • Overview
    • Market Share of Key Players in the Alopecia Market
      • 2.1. Global Company Market Share
      • 2.2. North America Company Market Share
      • 2.3. Europe Company Market Share
      • 2.4. APAC Company Market Share
    • Competitive Situations and Trends
      • 3.1. Product Launches and Developments
      • 3.2. Partnerships, Collaborations, and Agreements
      • 3.3. Mergers & Acquisitions
      • 3.4. Expansions

11. Company Profiles
    • Merck & Co. Inc.
      • 1.1. Business Overview
      • 1.2. Company Snapshot
      • 1.3. Company Market Share Analysis
      • 1.4. Company Product Portfolio
      • 1.5. Recent Developments
      • 1.6. SWOT Analysis
    • Lupin
      • 2.1. Business Overview
      • 2.2. Company Snapshot
      • 2.3. Company Market Share Analysis
      • 2.4. Company Product Portfolio
      • 2.5. Recent Developments
      • 2.6. SWOT Analysis
    • Abbott
      • 3.1. Business Overview
      • 3.2. Company Snapshot
      • 3.3. Company Market Share Analysis
      • 3.4. Company Product Portfolio
      • 3.5. Recent Developments
      • 3.6. SWOT Analysis
    • Hoffman-La Roche Ltd.
      • 4.1. Business Overview
      • 4.2. Company Snapshot
      • 4.3. Company Market Share Analysis
      • 4.4. Company Product Portfolio
      • 4.5. Recent Developments
      • 4.6. SWOT Analysis
    • Sanofi
      • 5.1. Business Overview
      • 5.2. Company Snapshot
      • 5.3. Company Market Share Analysis
      • 5.4. Company Product Portfolio
      • 5.5. Recent Developments
      • 5.6. SWOT Analysis
    • Eli Lilly and Company
      • 6.1. Business Overview
      • 6.2. Company Snapshot
      • 6.3. Company Market Share Analysis
      • 6.4. Company Product Portfolio
      • 6.5. Recent Developments
      • 6.6. SWOT Analysis
    • AbbVie Inc.
      • 7.1. Business Overview
      • 7.2. Company Snapshot
      • 7.3. Company Market Share Analysis
      • 7.4. Company Product Portfolio
      • 7.5. Recent Developments
      • 7.6. SWOT Analysis
    • Cipla Inc.
      • 8.1. Business Overview
      • 8.2. Company Snapshot
      • 8.3. Company Market Share Analysis
      • 8.4. Company Product Portfolio
      • 8.5. Recent Developments
      • 8.6. SWOT Analysis
    • Mylan N.V.
      • 9.1. Business Overview
      • 9.2. Company Snapshot
      • 9.3. Company Market Share Analysis
      • 9.4. Company Product Portfolio
      • 9.5. Recent Developments
      • 9.6. SWOT Analysis
    • GlaxoSmithKline
      • Business Overview
      • Company Snapshot
      • Company Market Share Analysis
      • Company Product Portfolio
      • Recent Developments
      • SWOT Analysis
    • Bayer AG
      • Business Overview
      • Company Snapshot
      • Company Market Share Analysis
      • Company Product Portfolio
      • Recent Developments
      • SWOT Analysis
    • Allergan
      • Business Overview
      • Company Snapshot
      • Company Market Share Analysis
      • Company Product Portfolio
      • Recent Developments
      • SWOT Analysis
    • Johnson & Johnson Private Limited
      • Business Overview
      • Company Snapshot
      • Company Market Share Analysis
      • Company Product Portfolio
      • Recent Developments
      • SWOT Analysis
    • Teva Pharmaceutical Industries Ltd.
      • Business Overview
      • Company Snapshot
      • Company Market Share Analysis
      • Company Product Portfolio
      • Recent Developments
      • SWOT Analysis

List of Table

1. Global Alopecia Market, By Disease Type, 2023–2030 (USD Billion)
2. Global Alopecia Areata, Alopecia Market, By Region, 2023–2030 (USD Billion)
3. Global Androgenetic Alopecia, Alopecia Market, By Region, 2023–2030 (USD Billion)
4. Global Cicatricial, Alopecia Market, By Region, 2023–2030 (USD Billion)
5. Global Traction, Alopecia Market, By Region, 2023–2030 (USD Billion)
6. Global Others, Alopecia Market, By Region, 2023–2030 (USD Billion)
7. Global Alopecia Market, By Treatment, 2023–2030 (USD Billion)
8. Global Devices, Alopecia Market, By Region, 2023–2030 (USD Billion)
9. Global Pharmaceuticals, Alopecia Market, By Region, 2023–2030 (USD Billion)
10. Global Alopecia Market, By End-User, 2023–2030 (USD Billion)
11. Global Homecare, Alopecia Market, By Region, 2023–2030 (USD Billion)
12. Global Dermatology Clinics, Alopecia Market, By Region, 2023–2030 (USD Billion)
13. Global Hospitals, Alopecia Market, By Region, 2023–2030 (USD Billion)
14. Global Others, Alopecia Market, By Region, 2023–2030 (USD Billion)
15. Global Alopecia Market, By Region, 2023–2030 (USD Billion)
16. North America Alopecia Market, By Disease Type, 2023–2030 (USD Billion)
17. North America Alopecia Market, By Treatment, 2023–2030 (USD Billion)
18. North America Alopecia Market, By End-User, 2023–2030 (USD Billion)
19. USA Alopecia Market, By Disease Type, 2023–2030 (USD Billion)
20. USA Alopecia Market, By Treatment, 2023–2030 (USD Billion)
21. USA Alopecia Market, By End-User, 2023–2030 (USD Billion)  
22. Canada Alopecia Market, By Disease Type, 2023–2030 (USD Billion)
23. Canada Alopecia Market, By Treatment, 2023–2030 (USD Billion)
24. Canada Alopecia Market, By End-User, 2023–2030 (USD Billion)
25. Mexico Alopecia Market, By Disease Type, 2023–2030 (USD Billion)
26. Mexico Alopecia Market, By Treatment, 2023–2030 (USD Billion)
27. Mexico Alopecia Market, By End-User, 2023–2030 (USD Billion)
28. Europe Alopecia Market, By Disease Type, 2023–2030 (USD Billion)
29. Europe Alopecia Market, By Treatment, 2023–2030 (USD Billion)
30. Europe Alopecia Market, By End-User, 2023–2030 (USD Billion)
31. Germany Alopecia Market, By Disease Type, 2023–2030 (USD Billion)
32. Germany Alopecia Market, By Treatment, 2023–2030 (USD Billion)
33. Germany Alopecia Market, By End-User, 2023–2030 (USD Billion)
34. France Alopecia Market, By Disease Type, 2023–2030 (USD Billion)
35. France Alopecia Market, By Treatment, 2023–2030 (USD Billion)
36. France Alopecia Market, By End-User, 2023–2030 (USD Billion)
37. UK Alopecia Market, By Disease Type, 2023–2030 (USD Billion)
38. UK Alopecia Market, By Treatment, 2023–2030 (USD Billion)
39. UK Alopecia Market, By End-User, 2023–2030 (USD Billion)
40. Italy Alopecia Market, By Disease Type, 2023–2030 (USD Billion)
41. Italy Alopecia Market, By Treatment, 2023–2030 (USD Billion)
42. Italy Alopecia Market, By End-User, 2023–2030 (USD Billion)
43. Spain Alopecia Market, By Disease Type, 2023–2030 (USD Billion)
44. Spain Alopecia Market, By Treatment, 2023–2030 (USD Billion)
45. Spain Alopecia Market, By End-User, 2023–2030 (USD Billion)
46. Asia Pacific Alopecia Market, By Disease Type, 2023–2030 (USD Billion)
47. Asia Pacific Alopecia Market, By Treatment, 2023–2030 (USD Billion)
48. Asia Pacific Alopecia Market, By End-User, 2023–2030 (USD Billion)
49. Japan Alopecia Market, By Disease Type, 2023–2030 (USD Billion)
50. Japan Alopecia Market, By Treatment, 2023–2030 (USD Billion)
51. Japan Alopecia Market, By End-User, 2023–2030 (USD Billion)
52. China Alopecia Market, By Disease Type, 2023–2030 (USD Billion)
53. China Alopecia Market, By Treatment, 2023–2030 (USD Billion)
54. China Alopecia Market, By End-User, 2023–2030 (USD Billion)
55. India Alopecia Market, By Disease Type, 2023–2030 (USD Billion)
56. India Alopecia Market, By Treatment, 2023–2030 (USD Billion)
57. India Alopecia Market, By End-User, 2023–2030 (USD Billion)
58. South America Alopecia Market, By Disease Type, 2023–2030 (USD Billion)
59. South America Alopecia Market, By Treatment, 2023–2030 (USD Billion)
60. South America Alopecia Market, By End-User, 2023–2030 (USD Billion)
61. Brazil Alopecia Market, By Disease Type, 2023–2030 (USD Billion)
62. Brazil Alopecia Market, By Treatment, 2023–2030 (USD Billion)
63. Brazil Alopecia Market, By End-User, 2023–2030 (USD Billion)
64. Middle East and Africa Alopecia Market, By Disease Type, 2023–2030 (USD Billion)
65. Middle East and Africa Alopecia Market, By Treatment, 2023–2030 (USD Billion)
66. Middle East and Africa Alopecia Market, By End-User, 2023–2030 (USD Billion)
67. UAE Alopecia Market, By Disease Type, 2023–2030 (USD Billion)
68. UAE Alopecia Market, By Treatment, 2023–2030 (USD Billion)
69. UAE Alopecia Market, By End-User, 2023–2030 (USD Billion)
70. South Africa Alopecia Market, By Disease Type, 2023–2030 (USD Billion)
71. South Africa Alopecia Market, By Treatment, 2023–2030 (USD Billion)
72. South Africa Alopecia Market, By End-User, 2023–2030 (USD Billion)

List of Figures 

1. Global Alopecia Market Segmentation
2. Alopecia Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Alopecia Market Attractiveness Analysis By Disease Type
9. Global Alopecia Market Attractiveness Analysis By Treatment
10. Global Alopecia Market Attractiveness Analysis By End-User
11. Global Alopecia Market Attractiveness Analysis By Region
12. Global Alopecia Market: Dynamics
13. Global Alopecia Market Share By Disease Type (2023 & 2030)
14. Global Alopecia Market Share By Treatment (2023 & 2030)
15. Global Alopecia Market Share By End-User (2023 & 2030)
16. Global Alopecia Market Share by Regions (2023 & 2030)
17. Global Alopecia Market Share by Company (2021)